Efficacy Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Kidney Injury

Share this content:
Efficacy Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Kidney Injury

Sponsor and Collaborators
CytoPherx, Inc Alquest

Contact
Rick Da Silva, RN
734-272-4772
rdasilva@cytopherx.com

Tina Leventhal, MS
734-272-4772
tleventhal@cytopherx.com

Principal Investigators
Ashita Tolwani, MD, Universityof Alabama Birmingham
Anitha Vijayan, MD, Washington University
Claude Galphin, MD, Memorial Hospital
Kevin Finkel, MD, University of Texas

ClinicalTrials.gov Identifier
NCT01400893
You must be a registered member of Renal and Urology News to post a comment.

Sign Up for Free e-newsletters